 | • レポートコード：QYR9ST02239 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、ポイントオブケア分子診断の世界市場について調査・分析し、ポイントオブケア分子診断の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（PCRベース、遺伝子シーケンスベース、ハイブリダイゼーションベース、マイクロアレイベース）、用途別（感染症、腫瘍学、血液学、出生前検査、内分泌学、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のポイントオブケア分子診断市場動向 ・主要企業別マーケットシェア ・ポイントオブケア分子診断の種類別市場規模2014-2019 （PCRベース、遺伝子シーケンスベース、ハイブリダイゼーションベース、マイクロアレイベース） ・ポイントオブケア分子診断の用途別市場規模2014-2019 （感染症、腫瘍学、血液学、出生前検査、内分泌学、その他） ・ポイントオブケア分子診断の北米市場：主要企業・種類別/用途別市場規模 ・ポイントオブケア分子診断のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・ポイントオブケア分子診断の中国市場：主要企業・種類別/用途別市場規模 ・ポイントオブケア分子診断の日本国内市場：主要企業・種類別/用途別市場規模 ・ポイントオブケア分子診断の東南アジア市場：主要企業・種類別/用途別市場規模 ・ポイントオブケア分子診断のインド市場：主要企業・種類別/用途別市場規模 ・ポイントオブケア分子診断の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Abbott Laboratories, Bayer Healthcare、F. Hoffmann-La Roche AG、Becton, Dickinson and Company、BioMerieux、Bio-Rad Laboratories, Inc.、Cepheid, Inc.、Danaher Corporation、Johnson and Johnson） ・ポイントオブケア分子診断の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Point-of-care (POC) diagnostics provide rapid actionable information for patient care at the time and site of an encounter with the health care system.Increased need for accurate and faster testing methods and results for the molecular tests is expected to propel the market growth.
In 2018, the global Point-of-Care Molecular Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Point-of-Care Molecular Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Point-of-Care Molecular Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott Laboratories, Bayer Healthcare
F. Hoffmann-La Roche AG
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Cepheid, Inc.
Danaher Corporation
Johnson and Johnson
Market segment by Type, the product can be split into
PCR-based
Genetic Sequencing-based
Hybridization-based
Microarray-based
Market segment by Application, split into
Infectious Diseases
Oncology
Hematology
Prenatal Testing
Endocrinology
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Point-of-Care Molecular Diagnostics status, future forecast, growth opportunity, key market and key players.
To present the Point-of-Care Molecular Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Point-of-Care Molecular Diagnostics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Point-of-Care Molecular Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 PCR-based
1.4.3 Genetic Sequencing-based
1.4.4 Hybridization-based
1.4.5 Microarray-based
1.5 Market by Application
1.5.1 Global Point-of-Care Molecular Diagnostics Market Share by Application (2019-2025)
1.5.2 Infectious Diseases
1.5.3 Oncology
1.5.4 Hematology
1.5.5 Prenatal Testing
1.5.6 Endocrinology
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Point-of-Care Molecular Diagnostics Market Size
2.2 Point-of-Care Molecular Diagnostics Growth Trends by Regions
2.2.1 Point-of-Care Molecular Diagnostics Market Size by Regions (2019-2025)
2.2.2 Point-of-Care Molecular Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Point-of-Care Molecular Diagnostics Market Size by by Players
3.1.1 Global Point-of-Care Molecular Diagnostics Revenue by by Players (2014-2019)
3.1.2 Global Point-of-Care Molecular Diagnostics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Point-of-Care Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Point-of-Care Molecular Diagnostics Key Players Head office and Area Served
3.3 Key Players Point-of-Care Molecular Diagnostics Product/Solution/Service
3.4 Date of Enter into Point-of-Care Molecular Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Point-of-Care Molecular Diagnostics Market Size by Type (2014-2019)
4.2 Global Point-of-Care Molecular Diagnostics Market Size by Application (2014-2019)
5 North America
5.1 North America Point-of-Care Molecular Diagnostics Market Size (2014-2019)
5.2 Point-of-Care Molecular Diagnostics Key Players in North America
5.3 North America Point-of-Care Molecular Diagnostics Market Size by Type
5.4 North America Point-of-Care Molecular Diagnostics Market Size by Application
6 Europe
6.1 Europe Point-of-Care Molecular Diagnostics Market Size (2014-2019)
6.2 Point-of-Care Molecular Diagnostics Key Players in Europe
6.3 Europe Point-of-Care Molecular Diagnostics Market Size by Type
6.4 Europe Point-of-Care Molecular Diagnostics Market Size by Application
7 China
7.1 China Point-of-Care Molecular Diagnostics Market Size (2014-2019)
7.2 Point-of-Care Molecular Diagnostics Key Players in China
7.3 China Point-of-Care Molecular Diagnostics Market Size by Type
7.4 China Point-of-Care Molecular Diagnostics Market Size by Application
8 Japan
8.1 Japan Point-of-Care Molecular Diagnostics Market Size (2014-2019)
8.2 Point-of-Care Molecular Diagnostics Key Players in Japan
8.3 Japan Point-of-Care Molecular Diagnostics Market Size by Type
8.4 Japan Point-of-Care Molecular Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Point-of-Care Molecular Diagnostics Market Size (2014-2019)
9.2 Point-of-Care Molecular Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Type
9.4 Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Application
10 India
10.1 India Point-of-Care Molecular Diagnostics Market Size (2014-2019)
10.2 Point-of-Care Molecular Diagnostics Key Players in India
10.3 India Point-of-Care Molecular Diagnostics Market Size by Type
10.4 India Point-of-Care Molecular Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Point-of-Care Molecular Diagnostics Market Size (2014-2019)
11.2 Point-of-Care Molecular Diagnostics Key Players in Central & South America
11.3 Central & South America Point-of-Care Molecular Diagnostics Market Size by Type
11.4 Central & South America Point-of-Care Molecular Diagnostics Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories, Bayer Healthcare
12.1.1 Abbott Laboratories, Bayer Healthcare Company Details
12.1.2 Company Description and Business Overview
12.1.3 Point-of-Care Molecular Diagnostics Introduction
12.1.4 Abbott Laboratories, Bayer Healthcare Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019))
12.1.5 Abbott Laboratories, Bayer Healthcare Recent Development
12.2 F. Hoffmann-La Roche AG
12.2.1 F. Hoffmann-La Roche AG Company Details
12.2.2 Company Description and Business Overview
12.2.3 Point-of-Care Molecular Diagnostics Introduction
12.2.4 F. Hoffmann-La Roche AG Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
12.2.5 F. Hoffmann-La Roche AG Recent Development
12.3 Becton, Dickinson and Company
12.3.1 Becton, Dickinson and Company Company Details
12.3.2 Company Description and Business Overview
12.3.3 Point-of-Care Molecular Diagnostics Introduction
12.3.4 Becton, Dickinson and Company Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
12.3.5 Becton, Dickinson and Company Recent Development
12.4 BioMerieux
12.4.1 BioMerieux Company Details
12.4.2 Company Description and Business Overview
12.4.3 Point-of-Care Molecular Diagnostics Introduction
12.4.4 BioMerieux Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
12.4.5 BioMerieux Recent Development
12.5 Bio-Rad Laboratories, Inc.
12.5.1 Bio-Rad Laboratories, Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Point-of-Care Molecular Diagnostics Introduction
12.5.4 Bio-Rad Laboratories, Inc. Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
12.5.5 Bio-Rad Laboratories, Inc. Recent Development
12.6 Cepheid, Inc.
12.6.1 Cepheid, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Point-of-Care Molecular Diagnostics Introduction
12.6.4 Cepheid, Inc. Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
12.6.5 Cepheid, Inc. Recent Development
12.7 Danaher Corporation
12.7.1 Danaher Corporation Company Details
12.7.2 Company Description and Business Overview
12.7.3 Point-of-Care Molecular Diagnostics Introduction
12.7.4 Danaher Corporation Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
12.7.5 Danaher Corporation Recent Development
12.8 Johnson and Johnson
12.8.1 Johnson and Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Point-of-Care Molecular Diagnostics Introduction
12.8.4 Johnson and Johnson Revenue in Point-of-Care Molecular Diagnostics Business (2014-2019)
12.8.5 Johnson and Johnson Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Point-of-Care Molecular Diagnostics Key Market Segments
Table Key Players Point-of-Care Molecular Diagnostics Covered
Table Global Point-of-Care Molecular Diagnostics Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer PCR-based Figures
Table Key Players of PCR-based
Figuer Genetic Sequencing-based Figures
Table Key Players of Genetic Sequencing-based
Figuer Hybridization-based Figures
Table Key Players of Hybridization-based
Figuer Microarray-based Figures
Table Key Players of Microarray-based
Table Global Point-of-Care Molecular Diagnostics Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Point-of-Care Molecular Diagnostics Market Share by Application in 2018 & 2025
Figure Infectious Diseases Case Studies
Figure Oncology Case Studies
Figure Hematology Case Studies
Figure Prenatal Testing Case Studies
Figure Endocrinology Case Studies
Figure Other Case Studies
Figure Point-of-Care Molecular Diagnostics Report Years Considered
Figure Global Point-of-Care Molecular Diagnostics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Size by Regions 2019-2025 (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Size by Regions 2019-2025 (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Share by Regions 2014-2019
Figure Global Point-of-Care Molecular Diagnostics Market Share by Regions 2014-2019
Figure Global Point-of-Care Molecular Diagnostics Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Point-of-Care Molecular Diagnostics Revenue by by Players (2014-2019) (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Share by by Players (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Market Share by by Players in 2018
Table Global Point-of-Care Molecular Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Point-of-Care Molecular Diagnostics Product/Solution/Service
Table Date of Enter into Point-of-Care Molecular Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Point-of-Care Molecular Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Size Share by Type (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Market Size Market Share by Type (2014-2019)
Table Global Point-of-Care Molecular Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Global Point-of-Care Molecular Diagnostics Market Size Share by Application (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Market Size Market Share by Application (2014-2019)
Figure Global Point-of-Care Molecular Diagnostics Revenue Market Share by Application in 2018
Figure North America Point-of-Care Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table North America Key Players Point-of-Care Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table North America Key Players Point-of-Care Molecular Diagnostics Market Share (2018-2019)
Table North America Point-of-Care Molecular Diagnostics Market Size by Type 2014-2019 (Million US$)
Table North America Point-of-Care Molecular Diagnostics Market Share by Type 2014-2019
Table North America Point-of-Care Molecular Diagnostics Market Size by Application 2014-2019 (Million US$)
Table North America Point-of-Care Molecular Diagnostics Market Share by Application 2014-2019
Figure Europe Point-of-Care Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table Europe Key Players Point-of-Care Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table Europe Key Players Point-of-Care Molecular Diagnostics Market Share (2018-2019)
Table Europe Point-of-Care Molecular Diagnostics Market Size by Type 2014-2019 (Million US$)
Table Europe Point-of-Care Molecular Diagnostics Market Share by Type 2014-2019
Table Europe Point-of-Care Molecular Diagnostics Market Size by Application 2014-2019 (Million US$)
Table Europe Point-of-Care Molecular Diagnostics Market Share by Application 2014-2019
Figure China Point-of-Care Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table China Key Players Point-of-Care Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table China Key Players Point-of-Care Molecular Diagnostics Market Share (2018-2019)
Table China Point-of-Care Molecular Diagnostics Market Size by Type 2014-2019 (Million US$)
Table China Point-of-Care Molecular Diagnostics Market Share by Type 2014-2019
Table China Point-of-Care Molecular Diagnostics Market Size by Application 2014-2019 (Million US$)
Table China Point-of-Care Molecular Diagnostics Market Share by Application 2014-2019
Figure Japan Point-of-Care Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table Japan Key Players Point-of-Care Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table Japan Key Players Point-of-Care Molecular Diagnostics Market Share (2018-2019)
Table Japan Point-of-Care Molecular Diagnostics Market Size by Type 2014-2019 (Million US$)
Table Japan Point-of-Care Molecular Diagnostics Market Share by Type 2014-2019
Table Japan Point-of-Care Molecular Diagnostics Market Size by Application 2014-2019 (Million US$)
Table Japan Point-of-Care Molecular Diagnostics Market Share by Application 2014-2019
Figure Southeast Asia Point-of-Care Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Point-of-Care Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Point-of-Care Molecular Diagnostics Market Share (2018-2019)
Table Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Point-of-Care Molecular Diagnostics Market Share by Type 2014-2019
Table Southeast Asia Point-of-Care Molecular Diagnostics Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Point-of-Care Molecular Diagnostics Market Share by Application 2014-2019
Figure India Point-of-Care Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table India Key Players Point-of-Care Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table India Key Players Point-of-Care Molecular Diagnostics Market Share (2018-2019)
Table India Point-of-Care Molecular Diagnostics Market Size by Type 2014-2019 (Million US$)
Table India Point-of-Care Molecular Diagnostics Market Share by Type 2014-2019
Table India Point-of-Care Molecular Diagnostics Market Size by Application 2014-2019 (Million US$)
Table India Point-of-Care Molecular Diagnostics Market Share by Application 2014-2019
Figure Central & South America Point-of-Care Molecular Diagnostics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Point-of-Care Molecular Diagnostics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Point-of-Care Molecular Diagnostics Market Share (2018-2019)
Table Central & South America Point-of-Care Molecular Diagnostics Market Size by Type 2014-2019 (Million US$)
Table Central & South America Point-of-Care Molecular Diagnostics Market Share by Type 2014-2019
Table Central & South America Point-of-Care Molecular Diagnostics Market Size by Application 2014-2019 (Million US$)
Table Central & South America Point-of-Care Molecular Diagnostics Market Share by Application 2014-2019
Table Abbott Laboratories, Bayer Healthcare Company Details
Table Abbott Laboratories, Bayer Healthcare Revenue in Point-of-Care Molecular Diagnostics Business 2014-2019 (Million US$)
Figure Abbott Laboratories, Bayer Healthcare Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2014-2019)
Table Abbott Laboratories, Bayer Healthcare Recent Development
Table F. Hoffmann-La Roche AG Company Details
Table F. Hoffmann-La Roche AG Revenue in Point-of-Care Molecular Diagnostics Business 2014-2019 (Million US$)
Figure F. Hoffmann-La Roche AG Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2014-2019)
Table F. Hoffmann-La Roche AG Recent Development
Table Becton, Dickinson and Company Company Details
Table Becton, Dickinson and Company Revenue in Point-of-Care Molecular Diagnostics Business 2014-2019 (Million US$)
Figure Becton, Dickinson and Company Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2014-2019)
Table Becton, Dickinson and Company Recent Development
Table BioMerieux Company Details
Table BioMerieux Revenue in Point-of-Care Molecular Diagnostics Business 2014-2019 (Million US$)
Figure BioMerieux Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2014-2019)
Table BioMerieux Recent Development
Table Bio-Rad Laboratories, Inc. Company Details
Table Bio-Rad Laboratories, Inc. Revenue in Point-of-Care Molecular Diagnostics Business 2014-2019 (Million US$)
Figure Bio-Rad Laboratories, Inc. Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2014-2019)
Table Bio-Rad Laboratories, Inc. Recent Development
Table Cepheid, Inc. Company Details
Table Cepheid, Inc. Revenue in Point-of-Care Molecular Diagnostics Business 2014-2019 (Million US$)
Figure Cepheid, Inc. Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2014-2019)
Table Cepheid, Inc. Recent Development
Table Danaher Corporation Company Details
Table Danaher Corporation Revenue in Point-of-Care Molecular Diagnostics Business 2014-2019 (Million US$)
Figure Danaher Corporation Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2014-2019)
Table Danaher Corporation Recent Development
Table Johnson and Johnson Company Details
Table Johnson and Johnson Revenue in Point-of-Care Molecular Diagnostics Business 2014-2019 (Million US$)
Figure Johnson and Johnson Revenue Growth Rate in Point-of-Care Molecular Diagnostics Business (2014-2019)
Table Johnson and Johnson Recent Development
Table Global Point-of-Care Molecular Diagnostics Market Size by Regions (Million US$) 2019-2025
Figure Global Point-of-Care Molecular Diagnostics Market Size Share by Regions (2019-2025)
Figure Global Point-of-Care Molecular Diagnostics Market Size Share by Regions in 2025
Figure North America Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure China Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure India Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Point-of-Care Molecular Diagnostics Market Size Forecast (2019-2025)(Million USD)
Table Global Point-of-Care Molecular Diagnostics Market Size by Product (2019-2025) (Million US$)
Figure Global Point-of-Care Molecular Diagnostics Market Size by Product (2019-2025)
Figure Global Point-of-Care Molecular Diagnostics Market Size by Product in 2025
Table Global Point-of-Care Molecular Diagnostics Market Size by Application (2019-2025) (Million US$)
Figure Global Point-of-Care Molecular Diagnostics Market Size by Application (2019-2025)
Figure Global Point-of-Care Molecular Diagnostics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の腫瘍学ベース分子診断市場：専門的調査 Molecular diagnosis of tumor refers to the molecular biological diagnosis technology with nucleic acid or protein as the core, which is an important method for early diagnosis of tumor. The global Oncology Based Molecular Diagnostics market was valued at xx million US$ in 2018 and will reach xx mill…- 腫瘍学分子診断の世界市場：市場規模・現状・予測 Molecular diagnostics is one of the most transformative and dynamic areas of diagnostics. It is a technique used for analyzing biological markers in proteome and genome. Molecular diagnostics tests are increasingly used in oncology, infectious disease, pharmacogenomics, and human leukocyte antigen t…
- 感染症検査における分子診断の世界市場：市場規模・現状・予測 Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used …
- ポイントオブケア感染症の世界市場：市場規模・現状・予測 A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.In 2018, the global Point of Care Infectiou…
- ポイントオブケア（POC）診断用ポリメラーゼ連鎖反応（PCR）の世界市場：市場規模・現状・予測 Point of Care (PoC) molecular diagnostics market is poised to witness robust growth over the forecast period. Increasing infectious diseases incidence coupled with growing public awareness levels pertaining to pre-disease detection to control its occurrence will drive PoC molecular diagnostics marke…